Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients. McNerney KO, Oranges K, Seif AE, Oshrine B, et al. J Pediatr Hematol Oncol 2022;44:e507-e511.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McNerney KO, Oranges K, Seif AE, Oshrine B, et al. Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients. J Pediatr Hematol Oncol 2022;44:e507-e511.
PMID: 35200224